NSECertificate under SEBI (Depositories and Participants) Regulations, 201810 Jul 2026 · 10 Jul 2026, 10:14 am

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Sudeep Pharma Limited · SUDEEPPHRM

✦ AI SummaryRegulatory

Sudeep Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming that all shares are held in electronic mode only.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sudeep Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Attachments (1)

📄

SUDEEPPHARMALIMITED_10072026101358_Submission_of_Certificate_under_Regulation_74_5__of_SEBI.pdf

pdf

Download →
View document text
Date: 10th July 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Bandra Kurla Phiroze Jeejeebhoy Towers Dalal Street, Complex, Bandra (E), Mumbai – 400051 Mumbai – 400001 Scrip Symbol- SUDEEPPHRM Scrip Code: 544619 Sub: Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th June 2026 Ref: Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 Dear Sir/Ma’am, We enclose herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Company’s Registrar and Share Transfer Agent, M/s. MUFG Intime India Private Limited for the quarter ended on 30th June 2026. Kindly take the same on record. Thanking you, For Sudeep Pharma Limited Dimple Mehta Company Secretary & Compliance Officer M. No.: F13184 ENCL: A/a CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) CIN: U67190MH1999PTC118368 Registered Address: C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400 083 Tel: +91 22 4918 6000 Email:Investor.helpdesk@in.mpms.mufg.com Website: https://in.mpms.mufg.com Ref. No. CSC/SUDEEP/2026 9th July 2026 Sudeep Pharma Limited 129/1/A, G.I.D.C. Estate, Nandesari, Vadodara – 391340,, Gujarat, India Kind Attn : Ms. Dimple Mehta Dear Madam, Subject: Confirmation Certificate in the matter of Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. We hereby confirm that during the quarter ended 30th June 2026 we have not received any demat request for processing as all shares of Sudeep Pharma Limited are held in electronic mode only. Kindly take note of the same in your records. Thanking you, Yours faithfully, For MUFG INTIME INDIA PRIVATE LIMITED (Formerly Link Intime India Private Limited) (Damodar Kambli) Assistant Vice President MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services